Key result
Optimal medical therapy yields zero cardiac events over 4 years in Masters athletes with obstructive CAD.
Why the study?
Cardiovascular risk rises with the increasing age and number of endurance Masters athletes, with coronary artery disease being the most common cause of sports-related sudden cardiac death in athletes over 35 years of age.
Does optimal medical therapy with or without revascularization prevent cardiac events in asymptomatic Masters athletes with obstructive coronary artery disease?
Case Report (n=6)
No
Does optimal medical therapy with or without revascularization prevent cardiac events in asymptomatic Masters athletes with obstructive coronary artery disease?
This series suggests that highly fit asymptomatic athletes with obstructive coronary artery disease may have a favorable prognosis on medical therapy without empirical revascularization.
Answers are grounded in this paper and cite their sources.
Supports conservative management in asymptomatic Masters athletes with obstructive CAD; hypothesis-generating and requires larger prospective validation.
BACKGROUND: Both the age and number of endurance Masters athletes is increasing; this coincides with increasing cardiovascular risk. The vast majority of sports-related sudden cardiac deaths (SCDs) occur among athletes >35 years of age. Coronary artery disease (CAD) is the most common cause of SCD amongst Masters athletes. CASE SUMMARY: In our prospective screening trial, six asymptomatic Masters athletes with ischaemia on electrocardiogram exercise stress testing had their coronary anatomy defined either by cardiac computed tomography or coronary angiography. Three patients underwent coronary angiography, with fractional flow reserve (FFR) testing performed when indicated. Subsequent percutaneous revascularization was performed in one patient after a shared-decision making process involving the patient and the referring cardiologist. All six athletes identified with obstructive CAD were male. The mean age and Framingham risk score was 61.8 years (±9.5) and 22.7% (±6.1), respectively. The mean metabolic equivalent of task achieved was 14.4 (±3.8). All athletes were treated with optimal medical therapy as clinically indicated. No cardiac events occured in 4.3 years of follow-up. DISCUSSION: Guidelines recommend revascularization of Masters athletes to alleviate the ischaemic substrate despite a paucity of evidence that revascularization will translate into a reduction in myocardial infarct or sudden cardiac arrest/death. Herein, although a limited study population, we demonstrate a lack of clinical events after 4.3 years of follow-up whether or not revascularization was performed. A prospective multicentre registry for asymptomatic Masters athletes with documented obstructive CAD is needed to help establish the role of revascularization in this population.
No takes yet. Share an insight, caveat, or question.
McKinney et al. (2020) conducted a case report in Obstructive coronary artery disease in asymptomatic Masters athletes (n=6). Optimal medical therapy with or without percutaneous revascularization was evaluated on Cardiac events. In 6 asymptomatic Masters athletes with obstructive coronary artery disease, optimal medical therapy with or without revascularization resulted in zero cardiac events over 4.3 years of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: